WallStreetZenWallStreetZen

NASDAQ: NTRA
Natera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NTRA

Based on 14 analysts offering 12 month price targets for Natera Inc

Min Forecast
$125.00-21.07%
Avg Forecast
$167.36+5.68%
Max Forecast
$200.00+26.29%

Should I buy or sell NTRA stock?

Based on 14 analysts offering ratings for Natera Inc.

Strong Buy
Strong Buy
10 analysts 71.43%
Buy
4 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their NTRA stock forecasts and price targets.

NTRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-17
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2025-01-03
lockedlocked$00.00+00.00%2024-12-13
lockedlocked$00.00+00.00%2024-11-18
Morgan Stanley
Bottom 7%
7
Strong BuyMaintains$176.00+11.14%2024-11-14
TD Cowen
Top 19%
82
Strong BuyMaintains$175.00+10.51%2024-11-13Find out why
Craig-Hallum
Top 25%
76
BuyMaintains$157.00-0.86%2024-11-13
Baird
Top 18%
83
BuyMaintains$160.00+1.04%2024-11-13
Leerink Partners
Bottom 2%
2
BuyMaintains$150.00-5.28%2024-10-17

1 of 2

Forecast return on equity

Is NTRA forecast to generate an efficient return?

Company
0.03%
Industry
-3.58%
Market
251.17%
NTRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NTRA forecast to generate an efficient return on assets?

Company
0.02%
Industry
10.82%
NTRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NTRA earnings per share forecast

What is NTRA's earnings per share in the next 2 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.30
Avg 2 year Forecast
$0.00

NTRA revenue forecast

What is NTRA's revenue in the next 2 years based on estimates from 7 analysts?

Avg 1 year Forecast
$1.8B+16.67%
Avg 2 year Forecast
$2.1B+36.99%
NTRA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NTRA revenue growth forecast

How is NTRA forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
16.67%
Industry
12.11%
Market
19%
NTRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NTRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NTRA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NTRA$158.36$167.36+5.68%Strong Buy
ILMN$136.67$165.13+20.83%Buy
LH$238.56$262.09+9.86%Buy
WAT$404.00$384.58-4.81%Hold
DGX$151.20$173.58+14.80%Buy
View Top Diagnostic & Research Stocks

Natera Stock Forecast FAQ

Is Natera Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: NTRA) stock is to Strong Buy NTRA stock.

Out of 14 analysts, 10 (71.43%) are recommending NTRA as a Strong Buy, 4 (28.57%) are recommending NTRA as a Buy, 0 (0%) are recommending NTRA as a Hold, 0 (0%) are recommending NTRA as a Sell, and 0 (0%) are recommending NTRA as a Strong Sell.

If you're new to stock investing, here's how to buy Natera stock.

What is NTRA's earnings growth forecast for 2025-2026?

(NASDAQ: NTRA) Natera's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 51.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.08%.

Natera's earnings in 2025 is -$214,686,000.On average, 7 Wall Street analysts forecast NTRA's earnings for 2025 to be -$171,627,061, with the lowest NTRA earnings forecast at -$215,193,930, and the highest NTRA earnings forecast at -$112,217,694.

In 2026, NTRA is forecast to generate $264,042 in earnings, with the lowest earnings forecast at -$55,448,743 and the highest earnings forecast at $59,409,367.

What is NTRA's revenue growth forecast for 2025-2026?

(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 16.67% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 12.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19%.

Natera's revenue in 2025 is $1,531,955,000.On average, 7 Wall Street analysts forecast NTRA's revenue for 2025 to be $235,967,537,498, with the lowest NTRA revenue forecast at $231,036,428,000, and the highest NTRA revenue forecast at $244,111,769,617.

In 2026, NTRA is forecast to generate $277,071,294,414 in revenue, with the lowest revenue forecast at $263,460,740,410 and the highest revenue forecast at $289,001,487,473.

What is NTRA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: NTRA) forecast ROA is 0.02%, which is lower than the forecast US Diagnostics & Research industry average of 10.82%.

What is NTRA's Price Target?

According to 14 Wall Street analysts that have issued a 1 year NTRA price target, the average NTRA price target is $167.36, with the highest NTRA stock price forecast at $200.00 and the lowest NTRA stock price forecast at $125.00.

On average, Wall Street analysts predict that Natera's share price could reach $167.36 by Jan 17, 2026. The average Natera stock price prediction forecasts a potential upside of 5.68% from the current NTRA share price of $158.36.

What is NTRA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: NTRA) Natera's current Earnings Per Share (EPS) is -$1.76. On average, analysts forecast that NTRA's EPS will be -$1.30 for 2025, with the lowest EPS forecast at -$1.63, and the highest EPS forecast at -$0.85. In 2026, NTRA's EPS is forecast to hit $0.00 (min: -$0.42, max: $0.45).

What is NTRA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: NTRA) forecast ROE is 0.03%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.